Antonella Surbone
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Antonella Surbone has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Paolo Tralongo
Medical Oncology Unit, Umberto I Hospital
2 shared publications - Antonino Carmelo Tralongo
Department of Clinical Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
1 shared publication - Diego Serraino
Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy
1 shared publication - Francesca Caspani
Medical Oncology Unit, ASST Sette Laghi, Circolo Hospital
1 shared publication Lea Baider
Sharett Institute of Oncology, Hadassah University Hospital
1 shared publication- Lea Baider
Hadassah University Hospital
1 shared publication
Latest Publications
- 7 October 2021
- Published by Springer Nature
- p. 417-424
Patients Categorization
- 22 August 2019
- Published by Wiley in European Journal of Cancer Care
- Vol. 28 (6) , e13139
Major patterns of cancer cure: Clinical implications
Introduction This review aimed to classify major patterns of cancer cure and discuss clinical implications. Patterns of cancer cure were identified, in terms of long‐term survival and life expectancy, by means of two recently estimated indicators: cure fraction (CF) and time to cure (TTC). Methods We considered population‐based studies reporting results for some cancer types on CF, defined as the proportion of patients who will reach the same life expectancy of the general population, or/and TTC, the time span necessary to experience a negligible excess mortality. TTC is obtained using conditional relative survival, which indicates the probability of surviving an additional y number of years, given that patients already survived x number of years. Results Four major patterns of cancer types emerged from published studies: (a) cancers with a CF > 60% and a TTC < 5 years (e.g., testicular, thyroid); (b) cancers with a CF between 20% and 50% and a TTC < 10 years (colon, rectum); (c) cancers showing a CF of approximately 50% and TTC > 10 years (breast, prostate and bladder); (d) cancers with a CF < 20% and uncertain TTC (lung or pancreas). Conclusion Clinical and social impact of “cancer cure” categorisation are discussed in details. Recognising a cancer patient as cured represents an opportunity to improve their quality of life.
- 22 August 2019
- Published by Wiley in European Journal of Cancer Care
- Vol. 28 (6) , e13139
Major patterns of cancer cure: Clinical implications
Introduction This review aimed to classify major patterns of cancer cure and discuss clinical implications. Patterns of cancer cure were identified, in terms of long‐term survival and life expectancy, by means of two recently estimated indicators: cure fraction (CF) and time to cure (TTC). Methods We considered population‐based studies reporting results for some cancer types on CF, defined as the proportion of patients who will reach the same life expectancy of the general population, or/and TTC, the time span necessary to experience a negligible excess mortality. TTC is obtained using conditional relative survival, which indicates the probability of surviving an additional y number of years, given that patients already survived x number of years. Results Four major patterns of cancer types emerged from published studies: (a) cancers with a CF > 60% and a TTC < 5 years (e.g., testicular, thyroid); (b) cancers with a CF between 20% and 50% and a TTC < 10 years (colon, rectum); (c) cancers showing a CF of approximately 50% and TTC > 10 years (breast, prostate and bladder); (d) cancers with a CF < 20% and uncertain TTC (lung or pancreas). Conclusion Clinical and social impact of “cancer cure” categorisation are discussed in details. Recognising a cancer patient as cured represents an opportunity to improve their quality of life.
- 6 October 2016
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 24 (12) , 4831-4833
Unequal cancer survivorship care: addressing cultural and sociodemographic disparities in the clinic
The number of individuals diagnosed with cancer is growing worldwide. Cancer patients from underserved populations have widely documented disparities through the continuum of cancer care. As the number of cancer survivors (i.e., individuals who have completed cancer treatment) from underserved populations also continue to grow, these individuals may continue to experience barriers to survivorship care, resulting in persistent long-term negative impacts on health and quality of life. In addition, there is limited participation of survivors from underserved populations in clinical trials and other research studies. To address disparities and change practices in survivorship care, a better understanding of the roles of both socioeconomic status (SES) and of culture in cancer care disparities and the relevance of these to providing high-quality care is needed. SES and culture often overlap but are not identical; understanding the impact of each is especially relevant to survivorship care. To enhance health equity among cancer survivors, clinicians need to practice culturally competent care, address cultural beliefs and practices that may influence survivors’ beliefs and activities, gain awareness of historical patterns of medical care in the survivor’s community, and consider how barriers to cross-cultural communications may hinder communication in clinical settings. While the design and implementation of survivorship care programs emphasizing effectiveness and equity is complex and potentially time consuming, it is critical for providing optimal care for all survivors, including those from the most vulnerable populations.
- 6 October 2016
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 24 (12) , 4831-4833
Unequal cancer survivorship care: addressing cultural and sociodemographic disparities in the clinic
The number of individuals diagnosed with cancer is growing worldwide. Cancer patients from underserved populations have widely documented disparities through the continuum of cancer care. As the number of cancer survivors (i.e., individuals who have completed cancer treatment) from underserved populations also continue to grow, these individuals may continue to experience barriers to survivorship care, resulting in persistent long-term negative impacts on health and quality of life. In addition, there is limited participation of survivors from underserved populations in clinical trials and other research studies. To address disparities and change practices in survivorship care, a better understanding of the roles of both socioeconomic status (SES) and of culture in cancer care disparities and the relevance of these to providing high-quality care is needed. SES and culture often overlap but are not identical; understanding the impact of each is especially relevant to survivorship care. To enhance health equity among cancer survivors, clinicians need to practice culturally competent care, address cultural beliefs and practices that may influence survivors’ beliefs and activities, gain awareness of historical patterns of medical care in the survivor’s community, and consider how barriers to cross-cultural communications may hinder communication in clinical settings. While the design and implementation of survivorship care programs emphasizing effectiveness and equity is complex and potentially time consuming, it is critical for providing optimal care for all survivors, including those from the most vulnerable populations.
- 1 October 2016
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (28) , 3372-3374
Categorization of Cancer Survivors: Why We Need It
- 1 October 2016
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (28) , 3372-3374
Categorization of Cancer Survivors: Why We Need It
- 19 March 2013
- Published by Springer Nature in Journal of Medicine and the Person
- Vol. 11 (1) , 11-18
Personal values and cultural diversity
- 19 March 2013
- Published by Springer Nature in Journal of Medicine and the Person
- Vol. 11 (1) , 11-18
Personal values and cultural diversity
- 2 June 2012
- Published by Springer Nature
- p. 3-13
From Truth Telling to Truth in the Making: A Paradigm Shift in Communication with Cancer Patients
- 2 June 2012
- Published by Springer Nature
- p. 3-13
From Truth Telling to Truth in the Making: A Paradigm Shift in Communication with Cancer Patients
- 1 November 2011
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 29 (31) , 4205-4206
The Black Dress
- 1 November 2011
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 29 (31) , 4205-4206
The Black Dress
- 1 December 2010
- Published by Elsevier in Surgical Oncology
- Vol. 19 (4) , 185-187
Reflections of a colleague and patient on truth telling, medical errors, and compassion
- 1 December 2010
- Published by Elsevier in Surgical Oncology
- Vol. 19 (4) , 185-187
Reflections of a colleague and patient on truth telling, medical errors, and compassion
- 31 October 2010
- Published by Elsevier in Journal of Geriatric Oncology
- Vol. 1 (2) , 45-47
Cultural competence in the practice of patient–family-centered geriatric oncology
- 31 October 2010
- Published by Elsevier in Journal of Geriatric Oncology
- Vol. 1 (2) , 45-47
Cultural competence in the practice of patient–family-centered geriatric oncology
- 1 February 1997
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 809 (1 Communic)
Foreword
- 1 February 1997
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 809 (1 Communic)
Foreword